Pathologically, CeD can lead to an inflammatory deterioration of the small intestinal mucosa (“flattened mucosa”) along with specific antibodies directed against gluten proteins (antigens) and tissue transglutaminase (autoantigen). The gene discussed is TGM2; the disease is cranioectodermal dysplasia.